Evaluation of GSK Biologicals' dTpa Booster Vaccine in Adults, Given 10 Years After Previous dTpa Boosting.
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2015
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 23 Oct 2008 Actual patient number (205) added as reported by ClinicalTrials.gov.
- 24 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Nov 2007 Status changed from initiated to recruiting.